Objectives The aim of this study was to investigate whether prolongation of the heart rate-corrected QT interval (QTc) is an independent risk factor for predicting future acute coronary syndrome (ACS) occurrence or mortality in patients with at least one cardiac risk factor presenting with chest pain to the emergency department (ED).
Introduction
The International Long QT Syndrome Registry found that the risk of developing malignant arrhythmias in patients with QT prolongation is exponentially related to the length of the QT interval [1] . However, the role of the heart rate-corrected QT interval (QTc) in prognostication in a population with no known coronary artery disease (CAD), versus those with CAD, is not known [2] [3] [4] [5] [6] [7] . The availability and widespread use of digitized ECG recordings for patients presenting with chest pain to the emergency department (ED) provide readily accessible data for determining the QTc interval.
Retrospective studies have found that QTc prolongation is associated with a higher risk of morbidity and mortality among patients with known CAD [1] . QTc prolongation has been associated with ventricular arrhythmias and increased mortality in acute coronary syndrome (ACS) patients [8, 9] . In contrast, population-based studies have shown no consistent association between QTc prolongation and the occurrence of ACS or mortality in a healthy asymptomatic population [2] [3] [4] [5] [6] [7] 10] . Further, the effect of QTc prolongation on clinical outcomes of patients who present to the ED with chest pain is not known. The objective of this study was to investigate whether QTc prolongation is an independent risk factor for predicting ACS occurrence or mortality in patients, with at least one cardiac risk factor, presenting to the ED with chest pain.
Methods
This was a retrospective review of the medical records of all patients 18 years or older presenting to the ED of Einstein Medical Center, Philadelphia, between June 2011 and June 2012 with chest pain, with known cardiac risk factors but no prior CAD history. Cardiac risk factors included hypertension, dyslipidemia, family history of CAD, diabetes mellitus, smoking, and obesity (BMI ≥ 26). This study was approved by the Einstein Medical Center Institutional Review Board.
Patients who were taking medications that prolong the QT interval (e.g. methadone, specific antiarrhythmics, antihistamines, antibiotics, and psychotropics), had electrolyte abnormalities (hypokalemia, hypocalcemia), had central nervous system injury, had known CAD, and had baseline atrial fibrillation or bundle branch block were excluded.
Demographic data including age, sex, BMI, hypertension, hyperlipidemia, diabetes mellitus, family history of premature CAD, and smoking status were collected from patient charts ( Tables 1 and 2 ). QTc intervals were collected from the index electrocardiogram and were classified as high or low on the basis of a cutoff point set at 460 ms (cutoff used in the majority of prior studies) [8, 9, 11] . The QT interval was corrected for heart rate in surface ECG using Bazett's formula. Electronic medical records of Einstein Medical Center, Philadelphia, were used to access subsequent ACS diagnoses. Patients were followed up for a mean of 1 year for subsequent ACS diagnosis or death (Social Security Death Index), whichever happened first. The Social Security Death Index was used to assess occurrence of death within 1 year after presentation to the ED.
For data analysis, patient groups were compared with and without QT prolongation with regard to each of the demographic variables using Student's t-tests for quantitative variables and χ 2 -tests for categorical variables. Hazard ratios were calculated for death or ACS within 1 year. Proportional hazards model/Cox model was constructed to adjust for the effect of demographics on mortality and ACS within 1 year and to calculate the adjusted hazard ratios. Kaplan-Meier curves were used to estimate the time to event for the QTc low and high groups. Log rank P-values were used to compare curves. JMP 10 (SAS, Cary, North Carolina, USA) was used for all statistical analyses. A P-value of 0.05 or less was considered statistically significant.
Results
Of the 700 charts reviewed, 105 charts were excluded: 58 because of the absence of any cardiac risk factor, 20 because of the absence of a baseline ECG at the ED visit, 12 because of atrial fibrillation or bundle branch block, and 13 because of electrolyte abnormalities or use of drugs known to prolong QTc. The mean follow-up period was 1 year from the index ED visit. Demographic variables were compared between groups with and without QT prolongation (Table 1) . Fifty-nine of the 595 (10%) patients studied experienced an ACS event during the index hospitalization and were not included in outcome measures. Patients with QTc greater than 460 were older (>60 years old) and had a higher incidence of hypertension, diabetes mellitus, and hyperlipidemia. Multivariate analysis for the composite of ACS and mortality was carried out to account for these significant demographic differences ( Table 2 ). Multivariate analysis demonstrated that a prolonged QTc was associated with a marked increase in the risk of having ACS or of death within 1 year after ED presentation. The Kaplan-Meier survival plot shows that ACS and mortality occurrence appears to increase at 4 months after the index presentation to the ED with chest pain (Fig. 1 ).
Discussion
The major finding of this study was that a prolonged QTc interval was associated with a more than seven-fold increase in the risk for ACS or death within 1 year of ED presentation for chest pain in patients with at least one cardiac risk factor. This was independent of other cardiac risk factors.
Epidemiological studies evaluating total and cardiovascular mortality associated with QTc prolongation have yielded conflicting results. The Framingham study failed to show an association of baseline QTc prolongation with total mortality, sudden death, or coronary mortality in a healthy population [12] . In contrast, the Cardiovascular Health Study showed an association between QTc greater than 450 ms and total mortality in a healthy population. In the Strong Heart Study, QTc greater than 460 ms was found to be associated with a two-fold increased risk for cardiac and total mortality in a healthy population [11] . In the Rotterdam Study, QTc prolongation greater than 440 ms was found to be associated with an increased risk for total and cardiovascular mortality in an elderly population [2] . A recent study by Beinart et al. [10] found that QTc greater than 460 ms or each 10 ms increase in the QTc of patients not known to have CAD was associated with an increased risk for future strokes, cardiovascular events, and heart failure readmissions. In the studies by Gadelata et al. [8] and Jiménez-Candil et al. [9] , prolongation of the QTc interval (>458 ms) on the admission ECG among patients with ACS was found to be an independent predictor of cardiovascular risk, defined as recurrence of ACS within 30 days or during 1 year of follow-up. In their studies, they found a positive correlation between prolonged QTc intervals and cardiac troponin T levels. To date, no study has examined the prognostic value of the QTc interval in patients presenting to the ED with chest pain. Thus, the present study extends the findings summarized above, in that patients presenting with chest pain to the ED with at least one cardiac risk factor are at increased risk for ACS events and all-cause death within 1 year if their QTc is greater than 460 ms. This is the first study to address a population of patients presenting to the ED symptomatic of chest pain and having at least one cardiac risk factor, but no known CAD or previous ACS. Factors that may affect QTc prolongation such as drugs and electrolyte abnormalities, which were not accounted for in most prior studies, were excluded in the present study. In addition, the interesting finding that BMI, defined in our study as BMI greater than 26, was also an independent risk factor for ACS and all-cause mortality within 1 year for patients presenting with chest pain and at least one cardiac risk factor is noteworthy. Further studies are needed to explore this finding.
This study was limited to a single center and was retrospective. We could not control for patients who may have gone to other medical centers for occurrence of a subsequent ACS within 1 year of follow-up. In addition, QTc was not manually calculated but was rather obtained from the computer-reported ECG taken at the index ED visit. However, this does reflect real-world care and offers an easy quick look predictor of future ACS and death risk among patients presenting to the ED with chest pain.
Conclusion
QTc prolongation at ED presentation among patients with chest pain with at least one cardiac risk factor is an independent risk factor for the occurrence of ACS or allcause mortality within 1 year. Whether this finding can be a potential add-on feature to risk scores, such as Thrombolysis in Myocardial Infarction, Global Registry of Acute Coronary Event, and Platelet Glycoprotein IIb/ IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy, will require prospective studies to confirm and compare the predictive value of QTc interval prolongation in patients presenting to the ED with chest pain [13] [14] [15] .
